SEC 13F Intelligence

Schroder Investment Management Group / ABT

Schroder Investment Management Group’s Abbott Laboratories Position

Does Schroder Investment Management Group own Abbott Laboratories (ABT)? Yes — 1.08M shares worth $110M (+0.09% of its 13F portfolio) as of Q1 2026, down from 1.23M shares the prior filed quarter.

Position Value
$110M
Q1 2026
Shares
1.08M
% of Portfolio
+0.09%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $11MQ4 ’18Q1 ’19: $55MQ2 ’19: $61MQ3 ’19: $74MQ4 ’19: $95MQ4 ’19Q1 ’20: $88MQ2 ’20: $123MQ3 ’20: $182MQ4 ’20: $460MQ4 ’20Q1 ’21: $247MQ2 ’21: $161MQ3 ’21: $139MQ4 ’21: $192MQ4 ’21Q1 ’22: $183MQ2 ’22: $190MQ3 ’22: $117MQ4 ’22: $129MQ4 ’22Q1 ’23: $104MQ2 ’23: $123MQ3 ’23: $102MQ4 ’23: $105MQ4 ’23Q1 ’24: $112MQ2 ’24: $105MQ3 ’24: $114MQ4 ’24: $122MQ4 ’24Q1 ’25: $147MQ2 ’25: $155MQ3 ’25: $168MQ4 ’25: $154MQ4 ’25Q1 ’26: $110Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.08M$110M+0.09%
Q4 20251.23M$154M+0.12%
Q3 20251.26M$168M+0.13%
Q2 20251.14M$155M+0.13%
Q1 20251.11M$147M+0.15%
Q4 20241.08M$122M+0.12%
Q3 2024998.8K$114M+0.12%
Q2 20241.01M$105M+0.12%
Q1 2024983.0K$112M+0.13%
Q4 2023956.1K$105M+0.14%
Q3 20231.05M$102M+0.15%
Q2 20231.13M$123M+0.18%
Q1 20231.03M$104M+0.15%
Q4 20221.17M$129M+0.20%
Q3 20221.21M$117M+0.19%
Q2 20221.75M$190M+0.29%
Q1 20221.52M$183M+0.24%
Q4 20211.37M$192M+0.25%
Q3 20211.18M$139M+0.21%
Q2 20211.39M$161M+0.20%
Q1 20212.06M$247M+0.32%
Q4 20204.20M$460M+0.32%
Q3 20201.71M$182M+0.29%
Q2 20201.35M$123M+0.22%
Q1 20201.07M$88M+0.19%
Q4 20191.10M$95M+0.16%
Q3 2019903.7K$74M+0.13%
Q2 2019721.8K$61M+0.11%
Q1 2019694.1K$55M+0.10%
Q4 2018148.0K$11M+0.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Schroder Investment Management Group’s full portfolio or all institutional holders of ABT.